Pacemaker, cardiac resynchonisation, implantable cardioverter/defibrillator, event monitoring

被引:0
|
作者
Klein, N. [1 ]
Klein, M. [1 ]
Pfeiffer, D. [1 ]
机构
[1] Univ Klinikum Leipzing, Abt Kardiol Angiol, D-04103 Leipzig, Germany
关键词
cardiac resynchonisation; pacemaker; implantable cardioverter/defibrillator; ICD; event monitoring; RESYNCHRONIZATION THERAPY; HEART-FAILURE; LEAD; PREVENTION; STIMULATION; EXPERIENCE; SYNCOPE; BLOCK;
D O I
10.1055/s-0033-1349644
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2526 / 2529
页数:4
相关论文
共 50 条
  • [31] The Subcutaneous Implantable Cardioverter Defibrillator
    Mangels, Daniel
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2016, 24 (05) : 248 - 255
  • [32] Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS-QI 33)
    Foo, Fang Shawn
    Lee, Mildred
    Looi, Khang-Li
    Larsen, Peter
    Clare, Geoffrey C.
    Heaven, David
    Stiles, Martin K.
    Voss, Jamie
    Boddington, Dean
    Jackson, Rod
    Kerr, Andrew J.
    JOURNAL OF ARRHYTHMIA, 2020, 36 (01) : 153 - 163
  • [33] Use of β-Blockers in Patients with an Implantable Cardioverter Defibrillator
    LaPointe, Nancy M. Allen
    Stafford, Judith A.
    Pappas, Paul A.
    Al-Khatib, Sana M.
    Anstrorn, Kevin J.
    ANNALS OF PHARMACOTHERAPY, 2009, 43 (7-8) : 1189 - 1196
  • [34] Implantable cardioverter defibrillator: What a hospital practitioner needs to know
    Albouaini, K.
    Mudawi, T.
    Pyatt, J. R.
    Wright, D. J.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2009, 20 (06) : 591 - 597
  • [35] THE INITIAL CLINICAL-EXPERIENCE WITH AN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR ANTITACHYCARDIA PACEMAKER
    SINGER, I
    AUSTIN, E
    NASH, W
    GILBO, J
    KUPERSMITH, J
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1991, 14 (07): : 1119 - 1128
  • [36] Combined therapy with transvenous implantable cardioverter/defibrillator and permanent pacemaker systems
    Sticherling, C
    Klingenheben, T
    Skupin, M
    Li, YG
    Hohnloser, SH
    ZEITSCHRIFT FUR KARDIOLOGIE, 1997, 86 (02): : 105 - 112
  • [37] Clinical Effect of Implantable Cardioverter Defibrillator Replacements - When Should You Resume Driving After an Implantable Cardioverter Defibrillator Replacement?
    Kawata, Hiro
    Noda, Takashi
    Kurita, Takashi
    Yamagata, Kenichiro
    Yamada, Yuko
    Okamura, Hideo
    Satomi, Kazuhiro
    Shimizu, Wataru
    Suyama, Kazuhiro
    Aihara, Naohiko
    Isobe, Mitsuaki
    Kamakura, Shiro
    CIRCULATION JOURNAL, 2010, 74 (11) : 2301 - 2307
  • [38] Update on cardiac implantable electronic devices: from the injectable loop recorder to the leadless pacemaker, to the subcutaneous defibrillator
    Santini, Massimo
    Santini, Luca
    Di Fusco, Stefania A.
    MINERVA CARDIOANGIOLOGICA, 2018, 66 (06): : 762 - 769
  • [39] The oral cavity is not a primary source for implantable pacemaker or cardioverter defibrillator infections
    Eberhard, Joerg
    Stumpp, Nico
    Ismail, Fadi
    Schnaidt, Ulrike
    Heuer, Wieland
    Pichlmaier, Maximilian
    Kuehn, Christian
    Haverich, Axel
    Stiesch, Meike
    JOURNAL OF CARDIOTHORACIC SURGERY, 2013, 8
  • [40] Incidence, Management, and Prevention of Right Ventricular Perforation by Pacemaker and Implantable Cardioverter Defibrillator Leads
    Migliore, Federico
    Zorzi, Alessandro
    Bertaglia, Emanuele
    Leoni, Loira
    Siciliano, Mariachiara
    De Lazzari, Manuel
    Ignatiuk, Barbara
    Veronese, Marta
    Verlato, Roberto
    Tarantini, Giuseppe
    Iliceto, Sabino
    Corrado, Domenico
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2014, 37 (12): : 1602 - 1609